πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

2,636 results for β€œ-” Clear

  1. edoxaban tosylate

    SAVAYSA

    ORAL FDA: approved

  2. edrophonium chloride

    TENSILON

    INJECTION FDA: approved

  3. efanesoctocog alfa

    ALTUVOCT

    EMA: approved

    B02BD02
  4. efavirenz, emtricitabine and tenofovir alafenamide

    EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

    ORAL FDA: approved

  5. efbemalenograstim alfa

    RYZNEUTA

    EMA: approved

    L03AA18
  6. efbemalenograstim alfa-vuxw

    RYZNEUTA

    INJECTION FDA: approved

  7. efgartigimod alfa

    VYVGART

    INJECTION FDA: approved Β· EMA: approved Β· PMDA: approved

    L04AA58
  8. efgartigimod alfa and hyaluronidase-qvfc

    VYVGART HYTRULO

    INJECTION FDA: approved

  9. eflapegrastim-xnst

    ROLVEDON

    SUBCUTANEOUS FDA: approved

  10. eflornithine hydrochloride

    ORNIDYL

    TOPICAL FDA: approved

  11. efmoroctocog alfa

    ELOCTA

    EMA: approved

    B02BD02
  12. eftrenonacog alfa

    ALPROLIX

    EMA: approved

    B02BD04
  13. elacestrant hydrochloride

    ORSERDU

    ORAL FDA: approved

  14. eladocagene exuparvovec

    UPSTAZA

    EMA: approved

    A16AB26
  15. elagolix sodium

    ORILISSA

    ORAL FDA: approved

  16. elagolix sodium,estradiol,norethindrone acetate

    ORIAHNN (COPACKAGED)

    ORAL FDA: approved

  17. elagolix, estradiol and norethindrone acetate and elagolix

    SHEUR Teva Pharma GmbH

    FDA: approved

  18. elamipretide hydrochloride

    FORZINITY

    SUBCUTANEOUS FDA: approved

  19. elapegademase-lvlr

    REVCOVI

    INJECTION FDA: approved

  20. eletriptan hydrobromide

    ELETRIPTAN HYDROBROMIDE Teva Pharma GmbH

    ORAL FDA: approved

  21. elexacaftor, ivacaftor, tezacaftor

    TRIKAFTA (COPACKAGED) Vertex Pharmaceuticals (Australia) Pty.

    ORAL FDA: approved

  22. eliglustat tartrate

    CERDELGA Teva Pharma GmbH

    ORAL FDA: approved Β· PMDA: approved

  23. elivaldogene autotemcel

    SKYSONA

    EMA: withdrawn

    N07
  24. elobixibat hydrate

    GOOFICE

    PMDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources